These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6608370)

  • 21. Immune-mediated aplastic anaemia.
    Corbeel L
    Eur J Pediatr; 2005 Nov; 164(11):698-9. PubMed ID: 15948000
    [No Abstract]   [Full Text] [Related]  

  • 22. Circulating activated suppressor T lymphocytes in aplastic anemia.
    Zoumbos NC; Gascón P; Djeu JY; Trost SR; Young NS
    N Engl J Med; 1985 Jan; 312(5):257-65. PubMed ID: 2981406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Severe aplastic anemia accompanied with abnormality of T cell subset and appearance of anti-BI antibody].
    Inada T; Abe K; Imamura N; Okada K; Kuramoto A
    Rinsho Ketsueki; 1989 Aug; 30(8):1314-8. PubMed ID: 2601051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of lymphocyte populations and natural killer activity in severe aplastic anaemia.
    De Souza MH; Pires AR; Diamond HR
    J Clin Lab Immunol; 1989 Nov; 30(3):111-6. PubMed ID: 2577148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell-mediated inhibition of haematopoiesis in aplastic anaemia: serial assay of inhibitory activities of T cells to autologous CFU-E during immunosuppressive therapy.
    Hanada T; Aoki Y; Ninomiya H; Abe T
    Br J Haematol; 1986 May; 63(1):69-74. PubMed ID: 3486672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cytofunctional significance of the lymphoid cellular population in aplastic pancytopenias. A search for a way (author's transl)].
    Sanchez Fayos J; Outeiriño J; Calabuig T; Valdes D; Paniagua G
    Sangre (Barc); 1974; 19(2):200-7. PubMed ID: 4547008
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunologic mechanisms in aplastic anemia.
    Finlay JL; Ershler WB; Shahidi NT
    Am J Pediatr Hematol Oncol; 1980; 2(3):223-32. PubMed ID: 7001943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Composition of the peripheral blood lymphoid population in hypoplastic anemias in children].
    Torubarova NA; Zamaraeva NV
    Pediatriia; 1982 Jun; (6):36-8. PubMed ID: 7133847
    [No Abstract]   [Full Text] [Related]  

  • 29. Insights into the autoimmune nature of aplastic anaemia.
    Marsh JC; Gordon-Smith EC
    Lancet; 2004 Jul 24-30; 364(9431):308-9. PubMed ID: 15276370
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunologic mechanisms in aplastic anemia. I. Introduction: Immunological system in aplastic anemia].
    Rupniewska ZM; Dmoszyńska-Giannopoulous A
    Przegl Lek; 1982; 39(9):607-11. PubMed ID: 6758055
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunologic defects in young male patients with hepatitis-associated aplastic anemia.
    Foon KA; Mitsuyasu RT; Schroff RW; McIntyre RE; Champlin R; Gale RP
    Ann Intern Med; 1984 May; 100(5):657-62. PubMed ID: 6608893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [B and T lymphocyte subpopulations in peripheral blood and bone marrow blood from aplastic anemia in childhood (author's transl)].
    Nakagawa T; Yata J; Nakayama K
    Rinsho Ketsueki; 1975 Sep; 16(9):850-8. PubMed ID: 175190
    [No Abstract]   [Full Text] [Related]  

  • 33. GM-CFC growth in chronic granulocytic leukaemia is not affected by a soluble inhibitor released by aplastic anaemia T-cells or mitogen-primed normal T-lymphocytes.
    Frassoni F; Podesta M; van Lint MT; Marmont A; Rossi E; Vimercati R; Bacigalupo A
    Br J Haematol; 1982 Apr; 50(4):647-53. PubMed ID: 6978148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of intracellular signal pathway of mTOR/S6 in CD3+ T lymphocytes of refractory/relapsed aplastic anemia patients].
    Zhang X; He GS; Wu DP; Sun AN; Miao M; Wang XL; Jin ZM; Qiu HY; Chang WR
    Zhonghua Xue Ye Xue Za Zhi; 2009 Oct; 30(10):654-7. PubMed ID: 19954658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Myelosuppressive T cells and aplastic anemia].
    Hoshino T; Takahashi T; Yagita M; Sugiyama H
    Nihon Rinsho; 1983; 41(4):808-14. PubMed ID: 6604179
    [No Abstract]   [Full Text] [Related]  

  • 36. Abnormal adherent cell function in aplastic anaemia demonstrated using levamisole in cultures for T lymphocyte colony-forming cells (TL-CFC).
    Gordon MY; King JA; Gordon-Smith EC
    Clin Exp Immunol; 1981 Apr; 44(1):117-23. PubMed ID: 6973426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed activation-induced T lymphocytes death in aplastic anemia: related with abnormal Fas system.
    Kim SC; Min YH; Lee S; Chung SY; Yoo NC; Lee JW; Hahn JS; Ko YW
    Korean J Intern Med; 1998 Feb; 13(1):41-6. PubMed ID: 9538630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hematologic diseases and T-cell dysfunction--multiple myeloma, T-cell leukemia, and aplastic anemia].
    Takatsuki K; Uchiyama T; Nagai K
    Nihon Rinsho; 1978; 36(5):977-84. PubMed ID: 353332
    [No Abstract]   [Full Text] [Related]  

  • 39. Defective stimulating capacity of leukocytes in mixed leukocyte culture in constitutional aplastic anemia caused by suppressor T cells. A case study.
    Kallenberg CG; Mulder NH; The TH; Speck B
    Acta Haematol; 1980; 63(2):81-7. PubMed ID: 6445153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic and functional T cell subset abnormalities in patients with aplastic anaemia and hypogammaglobulinaemia.
    Raziuddin S; Sheikha AK
    Br J Haematol; 1988 Nov; 70(3):283-7. PubMed ID: 3264716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.